Market Overview

O'Neill Innovations Agrees Exclusive Distribution Sales Agreement with Realy Tech Covid-19 Antibody Test Kits


ROME, Ga., July 13, 2020 /PRNewswire-PRWeb/ -- O'Neill Innovations today announced that it has successfully negotiated a contract with Hangzhou Realy Tech Co Ltd to act as Realy Tech's exclusive representative for sales of its SARS-CoV-2 Antibody test kits in the USA. The deal was completed in mid-March 2020 but is only being announced now as marketing ramps up for the test kits.

As part of the agreement, all product sales will be handled by O'Neill in the USA and it is anticipated that O'Neill will set up a distribution network that guarantees competitive pricing, clear territory assignment, quality control and compliance.

The new test kits have the capability to provide results for the presence of SARS-CoV-2 antibodies in human blood within 2 to 10 minutes. Unlike PCR tests that are prevalent in the market today, these test kits are a fraction of the cost, highly accurate and can be manufactured in high capacity.

The antibody tests do not require any complicated laboratory equipment or chemical reagents. They are not subject to the erroneous errors that occur with PCR sampling techniques and can be easily distributed for point of care testing at any location.

"Testing, testing, testing! We can distribute 90,000 test kits in a football stadium and have everyone tested in 10 minutes. The potential of this technology needs to be released to the public as soon as possible," said Michael O'Neill, CEO of O'Neill Innovations.

These test kits are regulated by the FDA and can only be used in a "Point of Care" facility with the guidance of a medical professional.

O'Neill Innovations products are highly differentiated and technology driven. They provide benefits that are simple to understand and performance that is easily understood.

O'Neill has curated the Hangzhou Realy Tech's Covid-19 Rapid Test because it aligns with this criterion for success.

For more information about these Covid-19 Antibody test please email or visit to join our distribution network.



View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at